Onychauxis is a common nail pathology characterised by a uniform thickening and hypertrophy of the nail plate, typically without significant structural deformity or lateral deviation. Often confused with onychogryphosis — a more severe condition involving pronounced curvature and distortion — onychauxis presents as a straightforward, though clinically significant, overgrowth of the nail. It most frequently affects the toenails, particularly the hallux (great toe), and is encountered regularly in podiatric practice. While the condition is not inherently dangerous, untreated onychauxis can lead to pain, subungual pressure, secondary infection, and considerable reduction in quality of life, particularly in elderly or immunocompromised populations. Understanding the aetiology, clinical presentation, and range of treatment options is essential for effective podiatric management.
Aetiology and Predisposing Factors
Onychauxis arises from a disruption in the normal mitotic activity of the nail matrix, which results in accelerated or abnormal nail cell production. This can be triggered by a variety of intrinsic and extrinsic factors. Repeated microtrauma — commonly caused by poorly fitting footwear, athletic activity, or prolonged pressure on the nail — is among the most frequent causes. The nail matrix, responding to chronic insult, overproduces keratinocytes, leading to progressive thickening of the nail plate over time.
Systemic conditions also play a significant aetiological role. Peripheral vascular disease, diabetes mellitus, and other conditions associated with poor circulation impair normal nail growth and repair mechanisms. Psoriasis is a notable dermatological cause, as it can affect the matrix and nail bed, producing thickened, dystrophic nails. Fungal infections, particularly onychomycosis caused by dermatophytes, are a major contributor to nail hypertrophy and must be differentiated from — or identified as co-existing with — onychauxis prior to formulating a treatment plan. Age-related changes in nail growth, circulation, and tissue elasticity mean that onychauxis is particularly prevalent in older adults.
Clinical Presentation and Assessment
Clinically, onychauxis presents as a uniformly thickened nail plate, often with a yellow, brown, or opaque discolouration. The nail surface may appear smooth or slightly ridged, and the nail is denser and harder than normal. Unlike onychogryphosis, the nail does not typically deviate laterally or assume a ram’s horn appearance. Patients may report difficulty cutting their nails, discomfort when wearing closed footwear, and occasionally pain at the nail margins due to pressure on the surrounding soft tissue.
A thorough clinical assessment is essential before initiating treatment. The clinician should evaluate neurovascular status, particularly in patients with diabetes or peripheral arterial disease, as compromised circulation affects healing and increases infection risk. The presence of fungal infection should be considered, and nail specimens may be sent for mycological analysis where onychomycosis is suspected. Assessment of footwear is also important, as ongoing mechanical trauma will undermine any intervention.
Conservative Treatment
The primary and most commonly employed treatment for onychauxis is conservative reduction of the nail plate through mechanical debridement. This is typically performed by a podiatrist using an electric burr or nail drill, which safely reduces the thickness of the nail without trauma to the underlying nail bed. The procedure is painless when performed correctly and results in immediate patient comfort. Following reduction, the nail is filed smooth to minimise pressure and friction within footwear.
Regular professional nail care is often necessary on an ongoing basis, as onychauxis tends to recur without addressing its underlying cause. Patients with systemic conditions or poor manual dexterity — particularly the elderly — benefit from scheduled podiatric appointments every six to ten weeks for maintenance.
Emollient therapy forms an important adjunct to mechanical reduction. Regular application of urea-based creams (typically 10–40% concentration) to the nail and surrounding tissue softens the nail plate, improves pliability, and facilitates easier debridement at subsequent appointments. Urea is keratolytic and helps to gradually reduce nail thickness when used consistently. Patient education around the daily application of emollients is an important component of a conservative management programme.
Footwear advice and orthotic intervention are valuable adjuncts. Patients should be guided towards footwear with a wide, deep toe box that reduces direct pressure on the nail. In cases where structural foot deformities — such as hallux valgus or digital contractures — contribute to nail trauma, orthotic devices or toe props may offload pressure and help prevent recurrence.
Treatment of Underlying Causes
Where onychomycosis is identified as a contributing or causative factor, antifungal therapy is indicated. Topical antifungals, such as amorolfine lacquer or ciclopirox, may be effective in mild to moderate cases, though their penetration of a thickened nail plate is limited. Systemic antifungals — most commonly terbinafine — are more effective for established fungal nail infection and are typically prescribed for twelve weeks for toenail involvement. Clinicians must assess suitability based on the patient’s medical history, medications, and liver function before initiating systemic therapy.
In patients with psoriatic nail disease, treatment of the underlying psoriasis — through topical corticosteroids, intralesional injections, or systemic biologics where indicated — may improve nail appearance and reduce hypertrophy. Dermatological referral may be appropriate in complex cases.
Surgical and Chemical Avulsion
In cases where onychauxis causes significant ongoing pain, recurring infections, or where conservative measures fail to provide adequate relief, more definitive intervention may be considered. Nail avulsion — either partial or total — involves the removal of the thickened nail plate under local anaesthesia. This provides immediate relief and allows inspection of the underlying nail bed for pathology.
Chemical matrixectomy using phenol (typically an 80–88% solution) is frequently performed following avulsion to permanently ablate all or part of the nail matrix, preventing regrowth. This is particularly appropriate when the nail is severely thickened, the patient cannot tolerate recurrent debridement, or where the nail serves no functional purpose. The procedure is well-tolerated and has a high success rate, though it requires careful wound management in the postoperative period, especially in patients with vascular compromise or diabetes.
Surgical excision of the nail matrix is an alternative to chemical ablation but is less commonly performed in routine podiatric practice due to its greater invasiveness and the adequacy of phenolisation in most cases.
Onychauxis, though a benign nail condition, warrants careful assessment and appropriate management to prevent pain, infection, and functional impairment. The cornerstone of treatment remains conservative debridement by a trained podiatrist, supported by emollient therapy, footwear advice, and management of any underlying systemic or dermatological conditions. In refractory or severely symptomatic cases, chemical matrixectomy offers a definitive and effective solution. A patient-centred, holistic approach — considering the individual’s overall health status, lifestyle, and goals — is essential to achieving the best outcomes in the treatment of this common foot condition.